Learning to Think at Lightspeed

Publication
Article
Pharmaceutical TechnologyThe Real Message Behind Commercial mRNA Products, April 2023 eBook
Volume 2023 eBook
Issue 3
Pages: 6–11

Actions combatting the next pandemic must be diverse, reliable, and sustainable.

Ampoules vaccine from coronavirus with syringe 3d render illustration on white. | Image Credit: © mylisa - mylisa - Stock.adobe.com

mylisa - Stock.adobe.com

World leaders have set ambitious goals to respond more swiftly to the next pandemic, including the United States’ goal to design, test, and review a new vaccine just 100 days after a pandemic declaration and to produce enough vaccines for the US and the world in 130 and 200 days. Past preparedness efforts have focused on innovation and reliability—culminating in the novel mRNA vaccines. Today, it’s important to consider diverse responses—and how the industry can make investments sustainable and “ready” for when an emergency happens.

Read this article in Pharmaceutical Technology’s The Real Message Behind Commercial mRNA Products eBook

About the author

Chris Spivey is editorial director of Pharmaceutical Technology.

Article details

Pharmaceutical Technology
eBook: The Real Message Behind Commercial mRNA Products
April 2023
Pages: 6–11

Citation

When referring to this article, please cite it as Spivey, C. Learning to Think at Lightspeed. Pharmaceutical Technology's The Real Message Behind Commercial mRNA Products eBook (April 2023).

Articles in this issue
mRNA with 5'Cap | Image Credit: ©scienceDISPLAY - Stock.adobe.com
Stability in mRNA-LNP Formulations
Test tube with DNA moleculeon abstract background,3d rendering,conceptual image. | Image Credit:©Shuo - Stock.adobe.com
Nucleic Acid-based Therapeutics Are Stepping into the Spotlight
Ampoules vaccine from coronavirus with syringe 3d render illustration on white. | Image Credit: © mylisa - mylisa - Stock.adobe.com
Learning to Think at Lightspeed
Covid-19 vaccine clinical research. Abstract background with infographics and images, 3d illustration. | Image Credit: ©Paulista - Stock.adobe.com
Managing mRNA Instability
scienziato osserva provetta, campione di analisi, scienza futuristica | Image Credit:©xyz+ - Stock.adobe.com
The Role of Separation Techniques in the Analysis of mRNA Therapeutic Drug Substances and Drug Products
Single strand ribonucleic acid, RNA research and therapy | Image Credit:©nobeastsofierce - Stock.adobe.com
The Marriage of RNA and Mass Spectrometry
Ribosome as part of an biological cell constructing messenger rna molecules - 3d illustration | Image Credit: ©Christoph Burgstedt - Stock.adobe.com
Delivering on the Potential of mRNA Therapeutics
ampoules with Covid-19 vaccine on a laboratory bench. to fight the coronavirus / sars-cov-2 pandemic. | Image Credit: ©M.Rode-Foto - Stock.adobe.com
The COVID-19 Pandemic and Its Positive Impact on RNA Drug Development
Recent Videos
Behind the Headlines, episode 7
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Orexo and Abera Partner to Develop Nasal Powder Vaccines

Feliza Mirasol
December 20th 2024
Article

The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Intertek Teams Up with CrystecPharma on Formulation and Development of Dry Powder Inhaler Products

Feliza Mirasol
December 13th 2024
Article

The partners will aim to establish a platform that enables rapid development of DPI products.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novartis Enters $2.9 Billion License Agreement with PTC Therapeutics for Huntington’s Disease Development Program

Feliza Mirasol
December 10th 2024
Article

Novartis will in-license PTC's PTC518 program, which has the potential become the first oral disease-modifying therapy for Huntington's disease.

Human head shape made from a large grid of pins connected with string. Communication technology and mental health concept | Image Credit: © ink drop - Stock.adobe.com

European Biotechs Unlocking Parkinson’s Disease

Cheryl Barton
December 9th 2024
Article

Centogene NV and ROPAD consortium publish data from a landmark study identifying genetic variants that may respond to innovative cell and gene therapies.